#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short-bowel syndrome Hormone-dependent prostate cancer Breast angiosarcoma metastatic Hyperadrenocorticism Liver abscess Von Willebrand's disease Proteus syndrome Hodgkin's disease refractory Hypersensitivity pneumonitis Fibrosarcoma metastatic Pyruvate dehydrogenase complex deficiency Encephalitis autoimmune Non-Hodgkin's lymphoma unspecified histology indolent Deafness bilateral Exudative retinopathy More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Basic Information Langerhans’ cell histiocytosis – Treatment Haemophilia A without inhibitors – Diagnostics Stevens-Johnson syndrome – Life with Disease Mucopolysaccharidosis II – Basic Information Mucopolysaccharidosis I – Life with Disease Primary hyperoxaluria – Trials in Disease Fragile X syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Hepatic angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tucidinostat Ranitidine Estriol Benfotiamine TRONTINEMAB Nvdx3 IBUZATRELVIR Dotatate Ecubectedin Bnt314 Phenol Olodaterol Nitrogen Cdr132L Acp-204 Tartrate Deucravacitinib Zibotentan Lurbinectedin Cefotaxime Specific Nucleic Acid Sna-Veru More therapies…

    Learn about Your Condition

    Mental disorder Malignant neoplasm of choroid Femoral hernia Rett syndrome Becker's muscular dystrophy Migraine Facial paresis Sepsis Glioblastoma Melanoma recurrent Drug eruption Mitral valve incompetence Post-traumatic headache Myofascial pain syndrome Solitary fibrous tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Cladribine
    • Recombinant Varicella Zoster Virus Glycoprotein E
    Belgium Bulgaria Czechia France Germany Greece +6

  • A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

    Recruiting

    3 1
    Investigated Drugs:
    • MOLNUPIRAVIR
    Bulgaria Finland France Germany Italy Poland +2

  • A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hypergammaglobulinaemia benign monoclonal
    • Plasma cell myeloma
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Dexamethasone Sodium Phosphate
    • Dexamethasone
    Belgium France Ireland Italy Poland Spain

  • A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hyperkalaemia
    Investigated Drugs:
    • Patiromer
    Belgium Finland France Greece Hungary Italy +5

  • Study comparing datopotamab deruxtecan with or without durvalumab to chemotherapy with pembrolizumab for patients with triple-negative breast cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Carboplatin
    • Durvalumab
    France Italy Poland Spain

  • Long-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Ustekinumab
    Belgium Bulgaria Czechia Denmark France Germany +6
Previous Page
1 … 72 73 74 75 76 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!